Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tempo Pharmaceuticals Inc.

This article was originally published in Start Up

Executive Summary

Tempo Pharmaceuticals produces nano-sized therapeutics designed to deliver a one-two punch: the targeted and sequential release of two drugs at a specific location in the body. Though the technology offers an improved way to deliver drugs, especially highly toxic chemotherapeutics to treat cancer, the company shies away from the drug delivery label. The company says its technology isn't just about getting drug into a tumor; it's about getting the right drug to the right location at the right time to address the microenvironment of the disease.
Advertisement

Related Content

TransGenex Nanobiotech Inc.
BIND Biosciences Inc.
Liquidia Technologies Inc.
Nanolymf Ltd.
Start-Up Previews (04/2008)
Nanotechnology: A Balm for the Challenges of Drug Delivery
Nanotechnology: A Balm for the Challenges of Drug Delivery
Start-Up Previews (04/2008)
Timing is Everything; Tempo Raises Series A
Timing is Everything; Tempo Raises Series A

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC091576

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel